-
TBST and Translational Confidence in uPAR Assays
2026-09-11
Mechanistic oncology studies depend on assay systems that distinguish real target engagement from background. This thought-leadership guide connects the uPAR·uPA inhibitor study with practical TBST strategy for Western blotting, immunofluorescence, immunohistochemistry, and other translational workflows.
-
TBST (Tris-Buffered Saline and Tween 20) Guide
2026-09-10
TBST is a ready-to-use buffered salt and Tween 20 solution for reducing nonspecific background during antibody-based workflows. It is appropriate for Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry, but requires validation in protocols sensitive to non-ionic detergents.
-
Sulfamonomethoxine Toxicity Across Aquatic Trophic Levels
2026-09-10
Huang and colleagues assessed sulfamonomethoxine toxicity across algae, cladocerans, and medaka, combining acute and chronic endpoints to improve ecological interpretation. The study found that microalgae were more sensitive than cladocerans, emphasizing the value of multi-trophic testing when evaluating veterinary antibiotic residues.
-
MK-8745: Translating Aurora A Biology
2026-09-09
A mechanistic and translational framework for using MK-8745, a potent and selective Aurora A inhibitor, to connect mitotic control with apoptosis, lymphoma biology, retinoblastoma research, and tumor xenograft strategy.
-
Prestained Protein Marker for ARID1A Studies
2026-09-09
Build more reliable ARID1A–PTEN–Akt immunoblot workflows with a triple-color ladder that supports separation checks, transfer monitoring, and fluorescence-compatible imaging. Its EDTA-free formulation is especially useful when Phosbind SDS-PAGE or phosphoprotein analysis is part of the experimental design.
-
Lycopene, ERK, and DON-Induced Gut Barrier Injury
2026-09-08
This 2025 study identifies ERK-linked signaling as a mechanistic point through which lycopene limits deoxynivalenol-induced intestinal barrier dysfunction and NLRP3 inflammasome activation in IPEC-J2 cells. Its findings connect oxidative stress, inflammatory signaling, and epithelial barrier injury while providing a pharmacological test of ERK involvement.
-
Ozone, Efferocytosis, and Neuropathic Pain
2026-09-08
The 2024 Frontiers in Immunology study identifies macrophage efferocytosis as a modifiable component of neuropathic pain and links ozone treatment to the AMPK/Gas6-MerTK/SOCS3 pathway. Its inhibitor experiments support a mechanistic model in which improved apoptotic-cell clearance suppresses inflammatory signaling in a chronic constriction injury model.
-
APEX-PS Maps RNA-Binding Proteins in Mitochondria
2026-09-07
The reference study introduces APEX-PS, a functional proximity-labeling strategy that combines compartment-targeted peroxidase labeling with enrichment of crosslinked protein–RNA complexes. Its application identified SYNJ2BP as an outer mitochondrial membrane RNA-binding protein that retains mitochondrial mRNAs during stress and supports recovery of local translation and oxidative phosphorylation.
-
IWP-L6: Precision Porcupine Inhibition Workflows
2026-09-07
IWP-L6 enables controlled Wnt signaling modulation from ligand maturation through developmental and metabolic readouts. This guide translates Porcn enzyme inhibition into practical workflows for HEK293 signaling assays, zebrafish tailfin regeneration, kidney branching studies, and Wnt-driven osteogenesis research.
-
Pentoxifylline and Preterm Monocyte Hyperinflammation
2026-09-05
The reference study shows that pentoxifylline suppresses LPS-driven inflammatory activation in monocytes from preterm and term infants, while also revealing age-dependent differences in surface-marker regulation and IL-10 production. Its integrated use of flow cytometry, functional phagocytosis testing, and TLR4 mRNA analysis provides a useful framework for interpreting neonatal immune modulation in vitro.
-
Resveratrol Rescues Radiation-Induced Endothelial Injury
2026-09-04
The reference study establishes an in vitro endothelial model for quantifying vascular and DNA damage caused by ionizing radiation. Its central finding is a hormetic, dose-dependent response to resveratrol, with 0.1 μM providing complete functional rescue of radiation-induced DNA damage and tube-formation impairment under the reported conditions.
-
Amplex Red for Reliable H2O2 Assays
2026-09-04
Amplex Red delivers sensitive fluorescence-based hydrogen peroxide and peroxidase measurements across mitochondrial, cellular, and enzyme workflows. Its major practical advantage is paired with a major caveat: carboxylesterase activity can generate resorufin without hydrogen peroxide, so robust assays require matrix-specific controls.
-
Capsazepine for Reliable Cell Assays
2026-09-03
Capsazepine (SKU A3279) offers a defined TRPV1 antagonist framework for troubleshooting variable viability, proliferation, and apoptosis assays. This scenario-based guide covers solvent control, concentration design, off-target interpretation, and practical supplier evaluation for more defensible cell-based experiments.
-
Targeted Tea Polyphenol Nanoparticles for AAA Therapy
2026-09-03
This 2025 ACS Applied Materials & Interfaces study develops cRGD-functionalized tea polyphenol nanoparticles that deliver doxycycline selectively to abdominal aortic aneurysm lesions. The platform combines integrin αvβ3 targeting, ROS-responsive drug release, and intrinsic antioxidant activity to address inflammation, oxidative stress, matrix degradation, apoptosis, and calcification while reducing doxycycline-associated organ toxicity.
-
BIBP 3226 Trifluoroacetate in Cardiac Signaling
2026-09-02
BIBP 3226 trifluoroacetate provides a practical pharmacological entry point for separating NPY Y1 and NPFF signaling in cAMP, neuronal, and cardiac models. This workflow-focused guide connects receptor antagonism with adipose-neural arrhythmia research while emphasizing controls, dosing logic, and troubleshooting.